Pattern Computer
Pattern Computer is a private AI platform company that has built the proprietary Pattern Discovery Engine (PDE) to uncover hidden patterns in high-dimensional data, serving biotech, pharmaceutical, healthcare, and enterprise customers through drug licensing, AI platform licensing, and hyperspectral diagnostics products.
- Company typePrivate
- Founded2016
- HeadquartersFriday Harbor, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Pattern Computer does
Pattern Computer, Inc. is a private AI platform company founded in 2016 and headquartered in Redmond, WA, with an additional Pattern Discovery Mathematics Center in San Diego, CA. The company has built its business around the proprietary Pattern Discovery Engine (PDE), a domain-agnostic, explainable AI system that uses novel mathematical techniques to reveal hidden relationships in complex, high-dimensional data that conventional neural networks and LLMs miss. Around the PDE core, Pattern Computer has assembled a portfolio of specialized products: ProSpectral (hyperspectral, reagent-free multi-disease diagnostics with EMC certification and 98.5% balanced COVID detection performance), PatternDE (the first online Pattern Discovery Engine for tabular data launched in January 2025), TrueXAI (decision-function extraction from neural networks), RC/XAI (risk-aware XAI for financial markets launched in 2025), AES (Adaptive Example Selection, peer-reviewed in Nature: Scientific Reports at 96% fidelity), and the investigational cancer therapy PCI020302 for triple-negative breast cancer, which holds global patent protection through 2040. The oncology pipeline also includes candidates for high-grade serous ovarian cancer (31 combination candidates identified computationally in 6 weeks), colorectal cancer (in collaboration with Fred Hutch and GECCO), glioblastoma, hepatocellular carcinoma, and metastatic castration-resistant prostate cancer.
Pattern Computer generates revenue through three primary streams: drug discovery and development licensing (anchored by PCI020302 and other oncology candidates), AI platform and technology licensing of the PDE to enterprise customers across biotech, finance, aerospace, veterinary, energy, and government research sectors, and commercialization of the ProSpectral diagnostics hardware. The PatternDE online platform introduces a subscription/usage-based self-serve component alongside the direct enterprise sales motion. Customer and partner evidence is concentrated in research collaborations rather than disclosed commercial accounts: named partners include Fred Hutch Cancer Research Center, University of Washington, Medical College of Wisconsin, Phenome Health, UCSD/Calit2, the J. Craig Venter Institute, and Scripps Research Institutes. The company has raised roughly $26.1M in disclosed funding (most recently in February 2022), operates with 11-50 employees, and has not announced institutional funding since, suggesting capital efficiency or founder/bootstrapped ownership. Distribution is dominated by direct enterprise engagement, conference-based business development (FiRe, BIO-Europe, J.P. Morgan Healthcare Conference, Life Science Innovation Northwest, AI.SUMMIT Hamburg), and scientific publications as thought leadership.
Pattern Computer firmographics
Firmographics- Name
- Pattern Computer
- Legal name
- Pattern Computer, Inc.
- Website
- https://patterncomputer.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Pattern Computer is a private AI platform company that has built the proprietary Pattern Discovery Engine (PDE) to uncover hidden patterns in high-dimensional data, serving biotech, pharmaceutical, healthcare, and enterprise customers through drug licensing, AI platform licensing, and hyperspectral diagnostics products.
- Ownership category
- akta.pro rank
Pattern Computer industry classification
Industry- Product category
- AI-Powered Pattern Discovery Platform
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Software Publishers (5132)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
- akta.pro secondary industries
- AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
Keywords
Where Pattern Computer is headquartered
LocationHeadquarters
- HQ city
- Friday Harbor
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Pattern Computer business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
Revenue model
- Drug Discovery & Development Licensing: Pattern Computer generates revenue through licensing its AI-discovered drug candidates to pharmaceutical partners, as well as advancing its own pipeline toward clinical development and commercialization. The company's PCI020302 triple-negative breast cancer therapy has an IP portfolio extending market exclusivity through 2040 across multiple geographies.
- AI Platform & Technology Licensing: The company licenses its Pattern Discovery Engine technology to enterprise customers across multiple sectors including biotech, diagnostics, materials science, aerospace manufacturing, veterinary medicine, air traffic operations, energy services, and finance. The online PatternDE platform enables subscription-based or usage-based access to pattern discovery capabilities.
- ProSpectral Diagnostics Platform: ProSpectral multi-disease hyperspectral diagnostics research platform is available for commercial deployment. The platform has passed EMC certifications required for commercial sales, enabling broad multi-disease screening applications.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Pattern Computer product offering
Product offeringCore offering
Pattern Computer develops and commercializes its proprietary Pattern Discovery Engine (PDE), an AI platform that uses novel mathematical techniques to find previously hidden, complex patterns in very-high-dimensional tabular data. The platform is domain-agnostic and produces explainable, hallucination-free insights applied across oncology drug discovery, hyperspectral multi-disease diagnostics (ProSpectral), risk-aware financial AI (RC/XAI), and fundamental physics research (Resonance Theory).
Product overview
Pattern Computer is a next-generation AI platform company that has developed a unified portfolio built around its proprietary Pattern Discovery Engine (PDE). The core offering is the Pattern Discovery Engine, which serves as the foundational platform for multiple specialized products and applications. The product suite includes ProSpectral for multi-disease diagnostics, PatternDE for online tabular data analysis, and PatternBio for drug discovery. Supporting these core offerings are TrueXAI and RC/XAI for explainable AI capabilities, AES (Adaptive Example Selection) for medical AI interpretability, and the PCI020302 investigational cancer therapy developed through AI-driven drug discovery. The company also maintains a Pattern Discovery Mathematics Center in San Diego for collaborative research. This platform-plus-modules architecture enables Pattern Computer to address applications across biotech, diagnostics, financial markets, and advanced AI research.
Differentiator
Problem solved
Functional benefit
Brands
- Pattern Discovery Engine (PDE): Proprietary AI platform for finding complex patterns in high-dimensional data
- PatternDE
- ProSpectral
- PatternBio
- TrueXAI
- RC/XAI
- AES (Adaptive Example Selection)
- ProSpectral
Products and services
- Pattern Discovery Engine (PDE) Proprietary AI platform using breakthrough pattern discovery algorithms to reveal previously hidden relationships in complex, high-dimensional data. Domain-agnostic, explainable, and capable of generating transparent, biologically validated insights for enterprise customers across biotech, finance, aerospace, and other sectors.
- PatternDE (Online Pattern Discovery Engine) The first commercial online Pattern Discovery Engine for transforming investigation, analysis, and modeling of high-dimensional tabular data into an intuitive and transparent process at scale, accessible via online subscription/usage-based access.
- ProSpectral Fast, accurate, multi-disease hyperspectral diagnostics platform that uses light-based spectral analysis for reagent-free, chemical-free disease screening. Delivers 98.5% balanced performance for COVID detection in 3-10 seconds. EMC certified for commercial sales.
- TrueXAI Explainable AI platform that derives previously hidden local manifolds from neural network models (including deep neural nets), extracting actual decision functions to turn neural networks from black boxes into glass boxes for full transparency of AI decision-making.
- RC/XAI (Risk and Confidence XAI) Next-generation risk-aware explainable AI tool for mission-critical applications, advancing trust and transparency in high-stakes decision making for financial markets and other regulated industries where risk and confidence quantification are essential.
- Adaptive Example Selection (AES) Framework Framework for medical AI interpretability that uses adaptive, contrastive example selection presenting both supporting and opposing evidence for each AI decision. Achieves 96% fidelity between predictions and explanations, validated in digital pathology for mitosis detection.
- PCI020302 (Triple-Negative Breast Cancer Therapy) Investigational AI-discovered novel combination therapy for triple-negative breast cancer (TNBC), an aggressive cancer subtype with limited treatment options. Available for licensing to pharmaceutical partners with global patent protection through 2040.
Quantifiable outcome
- 96% fidelity between AI predictions and explanations in digital pathology (mitosis detection)
- +4 more outcomes
Companies that use Pattern Computer
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles4 records
Pattern Computer technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature6 records
Pattern Computer partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Phenome HealthcorePattern Computer announced a partnership with Phenome Health in December 2024, deploying the Pattern Discovery Engine and ProSpectral platform to discover new drivers of human health. This partnership aligns with Pattern's expansion into broader health and wellness applications beyond oncology, leveraging hyperspectral diagnostics and pattern discovery for predictive health insights.
- Medical College of WisconsinminorPattern and the Medical College of Wisconsin launched a pilot study in August 2024 to assess detection of head, neck, and lung cancers through ProSpectral saliva analysis. This research collaboration aims to enable a new era of early detection cancer screening using Pattern's multi-disease hyperspectral diagnostics platform.
- UCSD (University of California San Diego)corePattern Computer established a Pattern Discovery Mathematics Center in San Diego in December 2021, anchored by a special agreement with the UCSD Regents on IP protection and sharing. The company has ongoing working relationships with UCSD's Dr. Larry Smarr, Professor Emeritus, and Chancellor Pradeep Khosla. UCSD's Calit2 (California Institute of Telecommunications and Information Technology) is part of the alliance structure.
- J. Craig Venter InstituteminorPattern Computer has established an alliance with the J. Craig Venter Institute as part of its expanded connections in the San Diego region, supporting the company's biotech and genomics-focused research initiatives.
- Scripps Research InstitutesminorPattern Computer has working relationships with the Scripps Research Institutes as part of its San Diego-based alliance structure supporting life sciences and biomedical research collaborations.
- Fred Hutch Cancer Research CentercorePattern Computer works with the Fred Hutch Cancer Research Center to obtain sufficient data on metastatic castration-resistant prostate cancer for Pattern Discovery Engine analysis. The partnership also provided data from the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) for colorectal cancer drug target discovery.
- University of WashingtoncorePattern Computer collaborated with University of Washington researchers to discover that the development of subepithelial infiltrates (SEI) due to conjunctivitis infection can be accurately predicted from knowledge of the full viral sequence. This research was published in Ophthalmology Science.
- National Clinical Testing OrganizationminorPattern Computer's ovarian cancer and other preclinical drug testing is conducted at a nationally-recognized clinical testing organization, engaging external laboratory services for in vitro and in vivo validation of AI-discovered drug candidates.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Pattern Computer competitors and assessment
Company assessmentDirect peers
- Atomwise: AI drug discovery company using structure-based deep learning to identify small molecule therapeutics. Comparable in using proprietary AI methods to discover drug candidates for hard-to-treat diseases.
- InSilico Medicine: AI-driven drug discovery and aging research company with end-to-end pipeline from target identification through clinical development. Comparable in applying AI to identify novel drug targets and candidates across multiple therapeutic areas.
- Insitro: Machine learning-driven drug discovery company combining high-throughput biology data with ML models. Directly comparable as an AI-native drug discovery company using data-driven approaches to identify novel therapeutics.
- XtalPi: AI-powered drug discovery company combining physics, chemistry, and machine learning for molecular design. Comparable in offering AI-based discovery platforms that identify novel drug candidates and accelerate development timelines.
- Schrödinger Inc. Computational chemistry and drug discovery platform combining physics-based modeling with machine learning. Comparable to Pattern's PDE for discovering drug candidates and therapeutic combinations through computational methods.
- Recursion Pharmaceuticals: AI-driven drug discovery company using high-dimensional biology data and machine learning to identify novel therapeutics. Directly comparable as a computational drug discovery platform pursuing AI-discovered drug candidates through preclinical and clinical development.
- BenevolentAI: AI-driven drug discovery company using knowledge graphs and machine learning to identify new drug targets. Comparable in applying AI to discover patterns in biomedical data and identify therapeutic candidates.
- Exscientia: AI-driven precision medicine company using its AI platform to accelerate small molecule drug discovery. Comparable to Pattern's PatternBio in applying AI to identify drug candidates and combinations.
Broad incumbents
- H2O.ai: Enterprise AI platform company providing machine learning and explainable AI tools for data analysis across industries. Comparable in offering AI-based pattern discovery and interpretability capabilities as an enterprise platform.
- Tempus Labs: AI-driven precision medicine company combining large-scale data analytics with healthcare applications. Comparable in applying AI to healthcare data for oncology and other therapeutic areas, with a broader portfolio than Pattern's drug discovery focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Pattern Computer social profiles
Digital presencePattern Computer compliance and trust
Trust signalCompliance1 record
Pattern Computer financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pattern Computer leadership team
Management profileNumber of profiles
Profiles9 records
Pattern Computer funding detail
Funding detailFunding overview
Funding rounds5 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pattern Computer M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pattern Computer
What does Pattern Computer do?
Pattern Computer develops and commercializes its proprietary Pattern Discovery Engine (PDE), an AI platform that uses novel mathematical techniques to find previously hidden, complex patterns in very-high-dimensional tabular data. The platform is domain-agnostic and produces explainable, hallucination-free insights applied across oncology drug discovery, hyperspectral multi-disease diagnostics (ProSpectral), risk-aware financial AI (RC/XAI), and fundamental physics research (Resonance Theory).
Is Pattern Computer a public or private company?
Pattern Computer is a private company. It is classified as venture growth investor backed and is currently operating.
When was Pattern Computer founded?
Pattern Computer was founded in 2016. It employs 11 to 50 people.
Where is Pattern Computer based?
Pattern Computer is headquartered in Friday Harbor, United States, in the North America region.
How does Pattern Computer make money?
Three revenue lines are on record. Drug Discovery & Development Licensing is the primary driver. The others are AI Platform & Technology Licensing and proSpectral Diagnostics Platform.
Who are Pattern Computer's main competitors?
Direct peers on record are Atomwise, InSilico Medicine, Insitro, XtalPi, Schrödinger Inc., Recursion Pharmaceuticals, BenevolentAI and Exscientia. Broad incumbents are H2O.ai and Tempus Labs.
Does Pattern Computer have an API?
No public API is recorded for Pattern Computer.
What industry is Pattern Computer in?
Pattern Computer's product category is AI-Powered Pattern Discovery Platform. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAAAIAE, AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening). Its NAICS code is 54171 and its SIC code is 2835.